ARTICLE | Clinical News
Oxabact regulatory update
September 29, 2014 7:00 AM UTC
The European Commission granted Orphan Drug designation to Oxabact from OxThera to treat short bowel syndrome (SBS). The capsule formulation of lyophilized live Oxalobacter formigenes has Orphan Drug ...